Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.21.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2021
Dec. 31, 2020
Current assets:    
Cash and cash equivalents $ 40,842,000 $ 17,564,000
Restricted cash 204,000 312,000
Accounts receivable, less allowance of $3,908 and $4,017 in 2021 and 2020, respectively 3,266,000 3,059,000
Inventory 11,877,000 11,157,000
Prepaid expenses and other current assets 1,560,000 3,018,000
Total current assets 57,749,000 35,110,000
Property, plant, and equipment, net 693,000 782,000
Goodwill 2,926,000 2,926,000
Right of use asset 1,890,000 1,976,000
Other assets 226,000 231,000
Total assets 63,484,000 41,025,000
Current liabilities:    
Accounts payable 3,072,000 2,651,000
Accrued liabilities 6,237,000 6,667,000
Deferred revenue, current portion 1,961,000 1,905,000
Total current liabilities 11,270,000 11,223,000
Deferred revenue 343,000 374,000
Warranty accrual 297,000 384,000
Non current term loans, net of discount 16,295,000 16,186,000
Non current operating lease liability 1,686,000 1,774,000
Other liabilities 77,000 1,056,000
Total liabilities 29,968,000 30,997,000
Commitments and contingencies — Note 11
Redeemable preferred stock:    
Series E Preferred stock, par value $0.001 per share; 1,000 shares authorized, 0 shares issued and outstanding as of March 31, 2021 and December 31, 2020
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 0 and 1 shares issued and outstanding as of March 31, 2021 and December 31, 2020, respectively 36,000 118,000
Common stock, par value $0.001 per share; 180,000 shares authorized, 149,427 and 97,709 shares issued and 149,382 and 97,663 outstanding as of March 31, 2021 and December 31, 2020, respectively 149,000 98,000
Additional paid-in-capital 292,141,000 261,573,000
Accumulated other comprehensive loss (533,000) (385,000)
Accumulated deficit (258,277,000) (251,376,000)
Total stockholders' equity 33,516,000 10,028,000
Total liabilities, redeemable preferred stock and stockholders' equity $ 63,484,000 $ 41,025,000